Hazlett, Burt & Watson’s Diebold Nixdorf Incorporated DBD Stock Holding History

Hazlett, Burt & Watson’s Portfolio DBD Stock Details DBD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-200	Closed	–	–	729
2023 Q1	$0	Hold	200	–	–	﹤0.01%	706
2022 Q4	$0	Hold	200	–	–	﹤0.01%	652
2022 Q3	$0	Hold	200	–	–	﹤0.01%	661
2022 Q2	$0	Hold	200	–	–	﹤0.01%	618
2022 Q1	$1K	Buy	+200	New	+$1.71K	﹤0.01%	580

Other funds holding DBD

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

BFIM

Beese Fulmer Investment Management Canton, Ohio $1.56B AUM 26.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Hazlett, Burt & Watson's DBD Position: Q2 2023 in Review

Hazlett, Burt & Watson sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2023, closing a stake of 200 shares.

Hazlett, Burt & Watson first reported a position in DBD in Q1 2022 and held it in 5 quarters. The position peaked at $1K in Q1 2022. 7 funds tracked by Wall St. Rank hold DBD as of Q2 2023.

Hazlett, Burt & Watson reported no remaining Diebold Nixdorf Incorporated position as of Q2 2023 after selling out during the quarter.
Hazlett, Burt & Watson sold 200 Diebold Nixdorf Incorporated shares in Q2 2023.
Hazlett, Burt & Watson first reported a position in Diebold Nixdorf Incorporated in Q1 2022 and held it in 5 quarters.
Hazlett, Burt & Watson's Diebold Nixdorf Incorporated position peaked at $1K in Q1 2022.
7 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2023.

Based on Hazlett, Burt & Watson's 13F filing for Q2 2023, filed 1 Aug 2023.